Legal & General Group Protection has announced revisions to its Group Critical Illness Cover, specifically updating definitions related to cancer, heart attack, and dementia.
The objective of these changes is to provide greater clarity to customers and their insured employees, aligning the product with the latest advances in diagnostic methods and treatments.
In terms of cancer, the revised guidelines allow for the inclusion of early-stage prostate cancers classified as below Gleason score 7, provided they have undergone treatment by prostatectomy. When it comes to dementia, the new definition consolidates Alzheimer’s with all other forms of dementia, aimed at offering clarity around what a diagnosis means and what is covered.
As for heart attacks, the updated definitions extend the evidence required for a definite diagnosis to include ‘typical clinical symptoms,’ such as characteristic chest pain.
James Walker, head of product and proposition at Legal & General Group Protection, said: “These latest changes aim to help ensure simplicity, reducing any confusion amongst intermediaries, business customers and insured employees alike. The modifications in cancer wording may also result in greater certainty when it comes to claims, providing reassurance at a vulnerable time and boosting confidence in the value of CIC.”
Walker added that the importance of Group CIC is growing among customers. “After seeing group CIC claims almost double in 2021 to £13.2m, up from £7.2m in 2020, our latest results announced earlier this year revealed another increase in 2022 to £18m.”
